BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26568293)

  • 1. Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo.
    Ma Y; Wei Z; Bast RC; Wang Z; Li Y; Gao M; Liu Y; Wang X; Guo C; Zhang L; Wang X
    Lab Invest; 2016 Jan; 96(1):37-48. PubMed ID: 26568293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of miR-383-5p suppresses proliferation and enhances chemosensitivity in ovarian cancer cells by targeting TRIM27.
    Jiang J; Xie C; Liu Y; Shi Q; Chen Y
    Biomed Pharmacother; 2019 Jan; 109():595-601. PubMed ID: 30399596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer.
    Zhang Y; Feng Y; Ji D; Wang Q; Qian W; Wang S; Zhang Z; Ji B; Zhang C; Sun Y; Fu Z
    Int J Oncol; 2018 Aug; 53(2):620-632. PubMed ID: 29767249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of TRIM27 expression suppresses the dysfunction of mesangial cells in lupus nephritis by FoxO1 pathway.
    Liu J; Feng X; Tian Y; Wang K; Gao F; Yang L; Li H; Tian Y; Yang R; Zhao L; Miao X; Huang J; Liu Q; Zhang W; Li Y; Wang C; Duan H; Liu S
    J Cell Physiol; 2019 Jul; 234(7):11555-11566. PubMed ID: 30648253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.
    Horio M; Kato T; Mii S; Enomoto A; Asai M; Asai N; Murakumo Y; Shibata K; Kikkawa F; Takahashi M
    Cancer Med; 2012 Oct; 1(2):218-29. PubMed ID: 23342271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of TRIM27 suppresses gastric cancer cell proliferation via inhibition of the Hippo-BIRC5 pathway.
    Yao Y; Liu Z; Cao Y; Guo H; Jiang B; Deng J; Xiong J
    Pathol Res Pract; 2020 Sep; 216(9):153048. PubMed ID: 32825933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM27 regulates the expression of PDCD4 by the ubiquitin‑proteasome pathway in ovarian and endometrial cancer cells.
    Yu H; Wan L; Tang Z; Yao C; Zhang D; Jiang M; Wang C; Liu Y; Xue C; Wang X; Shi Y; Zhang L; Wang X; Wei Z
    Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35583010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling.
    Liu S; Tian Y; Zheng Y; Cheng Y; Zhang D; Jiang J; Li S
    Aging (Albany NY); 2020 Dec; 12(24):25564-25580. PubMed ID: 33264103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the tripartite motif protein 27 in cancer development.
    Zoumpoulidou G; Broceño C; Li H; Bird D; Thomas G; Mittnacht S
    J Natl Cancer Inst; 2012 Jun; 104(12):941-52. PubMed ID: 22556269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM27 interacts with Iκbα to promote the growth of human renal cancer cells through regulating the NF-κB pathway.
    Xiao C; Zhang W; Hua M; Chen H; Yang B; Wang Y; Yang Q
    BMC Cancer; 2021 Jul; 21(1):841. PubMed ID: 34284744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136-5p/TRIM27.
    Mao Y; Ding Z; Jiang M; Yuan B; Zhang Y; Zhang X
    Biomed J; 2022 Dec; 45(6):883-895. PubMed ID: 34974169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAGED4B Promotes Glioma Progression via Inactivation of the TNF-α-induced Apoptotic Pathway by Down-regulating TRIM27 Expression.
    Liu C; Liu J; Shao J; Huang C; Dai X; Shen Y; Hou W; Shen Y; Yu Y
    Neurosci Bull; 2023 Feb; 39(2):273-291. PubMed ID: 35986882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
    Dai C; Xie Y; Zhuang X; Yuan Z
    Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo.
    Li R; Liu T; Shi J; Luan W; Wei X; Yu J; Mao H; Liu P
    J Transl Med; 2019 Dec; 17(1):428. PubMed ID: 31878941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway.
    Liu J; Xu J; Huang J; Gu C; Liu Q; Zhang W; Gao F; Tian Y; Miao X; Zhu Z; Jia B; Tian Y; Wu L; Zhao H; Feng X; Liu S
    Lab Invest; 2021 Aug; 101(8):983-997. PubMed ID: 33854173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.
    Lin Y; Xu T; Teng H; Cui M
    Int J Clin Exp Pathol; 2015; 8(9):10061-71. PubMed ID: 26617713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIM28 and TRIM27 are required for expressions of PDGFRβ and contractile phenotypic genes by vascular smooth muscle cells.
    Wang Y; Hao Y; Zhao Y; Huang Y; Lai D; Du T; Wan X; Zhu Y; Liu Z; Wang Y; Wang N; Zhang P
    FASEB J; 2020 May; 34(5):6271-6283. PubMed ID: 32162409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.